{
    "eid": "2-s2.0-85140041643",
    "title": "A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques",
    "cover-date": "2022-09-28",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Plant Science",
            "@code": "1110",
            "@abbrev": "AGRI"
        }
    ],
    "keywords": [
        "Baiya SARS-CoV-2 Vax 1",
        "COVID-19",
        "immunogenicity",
        "plant-produced recombinant protein",
        "SARS-CoV-2",
        "subunit vaccine"
    ],
    "authors": [
        "Narach Khorattanakulchai",
        "Kanjana Srisutthisamphan",
        "Balamurugan Shanmugaraj",
        "Suwimon Manopwisedjaroen",
        "Kaewta Rattanapisit",
        "Chalisa Panapitakkul",
        "Taratorn Kemthong",
        "Nutchanat Suttisan",
        "Suchinda Malaivijitnond",
        "Arunee Thitithanyanont",
        "Anan Jongkaewwattana",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 2,
    "ref-count": 67,
    "ref-list": [
        "New SARS-CoV-2 variants - clinical, public health, and vaccine implications",
        "Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum",
        "Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies",
        "Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines",
        "Potential applications of plant biotechnology against SARS-CoV-2",
        "Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants",
        "Recombinant hemagglutinin produced from Chinese hamster ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development",
        "Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac",
        "High-level expression and enrichment of norovirus virus-like particles in plants using modified geminiviral vectors",
        "Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model",
        "Pseudotype neutralization assays: from laboratory bench to data analysis",
        "The long road toward COVID-19 herd immunity: vaccine platform technologies and mass immunization strategies",
        "A statistically defined endpoint titer determination method for immunoassays",
        "Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity",
        "Magnifection\u2013a new platform for expressing recombinant vaccines in plants",
        "Adjuvants\u2014a balance between toxicity and adjuvanticity",
        "Vaccine breakthrough infections with SARS-CoV-2 variants",
        "High yield expression of leptospirosis vaccine candidates ligA and LipL32 in the methylotrophic yeast Pichia pastoris",
        "A plant-produced antigen elicits potent immune responses against West Nile virus in mice",
        "Contributions of the international plant science community to the fight against infectious diseases in humans - part 2: affordable drugs in edible plants for endemic and re-emerging diseases",
        "The role of plant expression platforms in biopharmaceutical development: possibilities for the future",
        "SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies",
        "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor",
        "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
        "Characterisation of SARS-CoV-2 lentiviral pseudotypes and correlation between pseudotype-based neutralisation assays and live virus-based micro neutralisation assays",
        "Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine",
        "SARS-CoV-2 vaccines in development",
        "A comprehensive overview on the production of vaccines in plant-based expression systems and the scope of plant biotechnology to combat against SARS-CoV-2 virus pandemics",
        "Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals",
        "Plant-based vaccines: the way ahead?",
        "Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia",
        "A recombinant protein containing highly conserved hemagglutinin residues 81-122 of influenza H5N1 induces strong humoral and mucosal immune responses",
        "Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases",
        "Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding",
        "Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel",
        "Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an emerging zoonotic respiratory pathogen in humans",
        "Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization",
        "Recombinant protein vaccines, a proven approach against coronavirus pandemics",
        "A perspective on the development of plant-made vaccines in the fight against Ebola virus",
        "Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses",
        "Mice immunized with the vaccine candidate hexapro spike produce neutralizing antibodies against SARS-CoV-2",
        "Cell entry mechanisms of SARS-CoV-2",
        "Plant molecular farming: a viable platform for recombinant biopharmaceutical production",
        "Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity",
        "Perspectives on monoclonal antibody therapy as potential therapeutic intervention for coronavirus disease-19 (COVID-19)",
        "SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines",
        "Neutralization of SARS-CoV-2 variants B.1.429 and B.1.351",
        "SARS-CoV-2 variants of concern are emerging in India",
        "Affordable oral health care: dental biofilm disruption using chloroplast made enzymes with chewing gum delivery",
        "Plant-produced receptor-binding domain of SARS-CoV-2 elicits potent neutralizing responses in mice and non-human primates",
        "Immunogenicity of a DNA vaccine candidate for COVID-19",
        "Recent development and future prospects of plant-based vaccines",
        "Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice",
        "Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70",
        "SARS-CoV-2: structure, biology, and structure-based therapeutics development",
        "Subunit vaccines against emerging pathogenic human coronaviruses",
        "Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7",
        "A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates",
        "Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials",
        "Expression and functional evaluation of biopharmaceuticals made in plant chloroplasts",
        "Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2",
        "Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60011947",
            "affilname": "Thailand National Center for Genetic Engineering and Biotechnology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011947",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "127008786",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127008786",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Baiya Phytopharm Co., Ltd.",
        "Second Century Fund",
        "Chulalongkorn University"
    ]
}